Clinical Significance of the Plasma Protein Binding of Rifampicin in the Treatment of Tuberculosis Patients.
Roger Karel VerbeeckBonifasius S SinguDan KibuulePublished in: Clinical pharmacokinetics (2020)
Keyphrases
- end stage renal disease
- mycobacterium tuberculosis
- ejection fraction
- chronic kidney disease
- pulmonary tuberculosis
- peritoneal dialysis
- prognostic factors
- binding protein
- emergency department
- patient reported outcomes
- hiv aids
- hepatitis c virus
- amino acid
- combination therapy
- transcription factor
- dna binding
- hiv infected
- antiretroviral therapy
- human immunodeficiency virus
- drug induced
- patient reported